×
About 2,825 results

ALLMedicine™ Ovarian Insufficiency Center

Research & Reviews  1,381 results

Body composition in women with premature ovarian insufficiency using hormone therapy an...
https://doi.org/10.1111/cen.14331
Clinical Endocrinology; Freitas A, Giraldo A et. al.

Sep 17th, 2020 - To compare body composition between women with premature ovarian insufficiency (POI) using hormone therapy and controls with normal ovarian function, and to correlate body composition with cardiovascular risk markers in the POI group. A case-contr...

Surgical approaches of drug-free in vitro activation and laparoscopic ovarian incision ...
https://doi.org/10.1016/j.fertnstert.2020.07.029
Fertility and Sterility; Tanaka Y, Hsueh AJ et. al.

Sep 10th, 2020 - To demonstrate our procedures of drug-free in vitro activation (IVA) for treating patients with premature ovarian insufficiency (POI) or diminished ovarian reserve (DOR), as well as the laparoscopic ovarian incision (LOI) procedure for treating pa...

Premature ovarian insufficiency: an International Menopause Society White Paper.
https://doi.org/10.1080/13697137.2020.1804547
Climacteric : the Journal of the International Menopause Society; Panay N, Anderson RA et. al.

Sep 8th, 2020 - The aim of this International Menopause Society White Paper on premature ovarian insufficiency (POI) is to provide the latest information regarding this distressing condition. The impact of POI has far-reaching consequences due to its impact on ge...

Genetics of premature ovarian insufficiency and the association with X-autosome translo...
https://doi.org/10.1530/REP-20-0338
Reproduction (Cambridge, England); Di-Battista A, Moysés-Oliveira M et. al.

Aug 25th, 2020 - Premature ovarian insufficiency (POI) is the cessation of menstruation before the age of 40 and can result from different etiologies, including genetic, autoimmune, and iatrogenic. Of the genetic causes, single-gene mutations and cytogenetic alter...

Endothelial cell-specific-molecule-1 (endocan) levels in women with premature ovarian i...
https://doi.org/10.1080/01443615.2020.1789952
Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology; Ovayolu A, Karaman E et. al.

Aug 17th, 2020 - There is an increased risk of cardiovascular disease in women with premature ovarian insufficiency (POI). A relationship between cardiovascular disease and endocan levels has been shown. Endocan is a marker that is prominent in many diseases cause...

see more →

Guidelines  7 results

Committee Opinion No. 698: Hormone Therapy in Primary Ovarian Insufficiency.
https://doi.org/10.1097/AOG.0000000000002044
Obstetrics and Gynecology;

Apr 20th, 2017 - Primary ovarian insufficiency describes a spectrum of declining ovarian function and reduced fecundity due to a premature decrease in initial follicle number, an increase in follicle destruction, or poor follicular response to gonadotropins. The s...

Committee Opinion No. 698 Summary: Hormone Therapy in Primary Ovarian Insufficiency.
https://doi.org/10.1097/AOG.0000000000002040
Obstetrics and Gynecology;

Apr 20th, 2017 - Primary ovarian insufficiency describes a spectrum of declining ovarian function and reduced fecundity due to a premature decrease in initial follicle number, an increase in follicle destruction, or poor follicular response to gonadotropins. The s...

The British Menopause Society and Women's Health Concern recommendations on the managem...
https://doi.org/10.1177/2053369117699358
Post Reproductive Health; Hamoda H,

Apr 6th, 2017 - The British Menopause Society and Women's Health Concern recommendations on the management of women with premature ovarian insufficiency.|2017|Hamoda H, ,|epidemiology,etiology,adverse effects,methods,etiology,complications,drug therapy,etiology,p...

ESHRE Guideline: management of women with premature ovarian insufficiency.
https://doi.org/10.1093/humrep/dew027
Human Reproduction (Oxford, England); , Webber L et. al.

Mar 24th, 2016 - What is the optimal management of women with premature ovarian insufficiency (POI) based on the best available evidence in the literature? The guideline development group (GDG) formulated 99 recommendations answering 31 key questions on the diagno...

ACMG Standards and Guidelines for fragile X testing: a revision to the disease-specific...
https://doi.org/10.1038/gim.2013.61
Genetics in Medicine : Official Journal of the American College of Medical Genetics; Monaghan KG, Lyon E et. al.

Jun 14th, 2013 - Molecular genetic testing of the FMR1 gene is commonly performed in clinical laboratories. Mutations in the FMR1 gene are associated with fragile X syndrome, fragile X tremor ataxia syndrome, and premature ovarian insufficiency. This document prov...

see more →

Clinicaltrials.gov  1,415 results

Body composition in women with premature ovarian insufficiency using hormone therapy an...
https://doi.org/10.1111/cen.14331
Clinical Endocrinology; Freitas A, Giraldo A et. al.

Sep 17th, 2020 - To compare body composition between women with premature ovarian insufficiency (POI) using hormone therapy and controls with normal ovarian function, and to correlate body composition with cardiovascular risk markers in the POI group. A case-contr...

Surgical approaches of drug-free in vitro activation and laparoscopic ovarian incision ...
https://doi.org/10.1016/j.fertnstert.2020.07.029
Fertility and Sterility; Tanaka Y, Hsueh AJ et. al.

Sep 10th, 2020 - To demonstrate our procedures of drug-free in vitro activation (IVA) for treating patients with premature ovarian insufficiency (POI) or diminished ovarian reserve (DOR), as well as the laparoscopic ovarian incision (LOI) procedure for treating pa...

Premature ovarian insufficiency: an International Menopause Society White Paper.
https://doi.org/10.1080/13697137.2020.1804547
Climacteric : the Journal of the International Menopause Society; Panay N, Anderson RA et. al.

Sep 8th, 2020 - The aim of this International Menopause Society White Paper on premature ovarian insufficiency (POI) is to provide the latest information regarding this distressing condition. The impact of POI has far-reaching consequences due to its impact on ge...

Genetics of premature ovarian insufficiency and the association with X-autosome translo...
https://doi.org/10.1530/REP-20-0338
Reproduction (Cambridge, England); Di-Battista A, Moysés-Oliveira M et. al.

Aug 25th, 2020 - Premature ovarian insufficiency (POI) is the cessation of menstruation before the age of 40 and can result from different etiologies, including genetic, autoimmune, and iatrogenic. Of the genetic causes, single-gene mutations and cytogenetic alter...

Endothelial cell-specific-molecule-1 (endocan) levels in women with premature ovarian i...
https://doi.org/10.1080/01443615.2020.1789952
Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology; Ovayolu A, Karaman E et. al.

Aug 17th, 2020 - There is an increased risk of cardiovascular disease in women with premature ovarian insufficiency (POI). A relationship between cardiovascular disease and endocan levels has been shown. Endocan is a marker that is prominent in many diseases cause...

see more →

News  9 results

No increase in primary ovarian insufficiency with HPV vaccine
https://www.mdedge.com/obgyn/article/172987/vaccines/no-increase-primary-ovarian-insufficiency-hpv-vaccine
Bianca Nogrady

Aug 21st, 2018 - The human papillomavirus vaccine does not appear to be associated with an increased risk of ovarian insufficiency, according to researchers. Choreograph/Thinkstock Allison L.

VIDEO: Dr. Matteo Lambertini answers questions on temporary ovarian suppression
https://www.mdedge.com/obgyn/article/153819/breast-cancer/video-dr-matteo-lambertini-answers-questions-temporary-ovarian
Susan London

Dec 7th, 2017 - SAN ANTONIO – A meta-analysis of five trials among 873 premenopausal women with early breast cancer finds that temporarily suppressing ovarian function with a gonadotropin-releasing hormone analog during chemotherapy helps preserve fertility, redu.

ESHRE writes first premature ovarian insufficiency guidelines
https://www.mdedge.com/internalmedicine/article/86417/gynecology/eshre-writes-first-premature-ovarian-insufficiency
Mitchel L. Zoler

Aug 12th, 2014 - MUNICH – A working group of the European Society of Human Reproduction and Embryology drafted the first international guidelines for managing premature ovarian insufficiency. Once formally released, by late this year or soon after, the guidelines.

Procedure Beats Ovarian Deficit, Baby Born
https://www.medpagetoday.com/obgyn/pregnancy/41979

Sep 30th, 2013 - Action Points The investigators demonstrated that fragmentation of murine ovaries and disruption of ovarian Hippo signaling led to promotion of follicle growth and the generation of oocytes. They were able to show that using these procedures for t...

Primer Offers Pearls on Pediatric Primary Ovarian Insufficiency
https://www.mdedge.com/familymedicine/article/54695/adolescent-medicine/primer-offers-pearls-pediatric-primary-ovarian/page/0/1
Pediatric News;

May 30th, 2012 - Following diagnosis of POI, consider annual, routine surveillance for endocrine disorders. Test for complete blood count, complete metabolic panel, calcium, phosphorus, fasting glucose, insulin, thyroid stimulating hormone, and thyroid peroxidase.

see more →

Patient Education  13 results see all →